TGINSIGHT SIMILAR POSTS
Изворен канал @pythonotes · Post #172 · 26 окт.
Метод строки isidentifier() поможет узнать, подходит ли данная строка в качестве имени объекта. Вполне может заменить самостоятельно придуманную регулярку. >>> 'some_name'.isidentifier() True Обычное имя переменной >>> '私は手紙です'.isidentifier() True Юникод в качестве имени тоже доступен >>> '1_name'.isidentifier() False Имя не может начинаться с цифры >>> '੬_name'.isidentifier() False Включая все цифры юникода >>> 'some name'.isidentifier() False Пробелы недопустимы #basic
Hashtags
Пребарај: #clinicalstage
@venturevillagewall · Post #3534 · 20.12.2024 г., 09:31
$2.16M Fundraising by Umecrine Umecrine Cognition, a Swedish clinical-stage pharmaceutical firm, has raised $2.16 million to advance its innovative drug development targeting neurological disorders. The funding round took place on December 19, 2024. #UmecrineCognition#Pharmaceuticals#NeurologicalDisorders#Funding#Healthcare#ClinicalStage#Sweden
@venturevillagewall · Post #3642 · 21.12.2024 г., 10:23
PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment
@venturevillagewall · Post #3412 · 18.12.2024 г., 12:11
$60M Funding for Psioxus Psioxus Therapeutics has successfully secured $60M in funding as part of its latest round, scheduled for December 17, 2024. This funding aims to advance its innovative tumor gene therapy platform focused on improving cancer treatment outcomes. #Funding#Cancer#Biotech#Oncology#GeneTherapy#Therapeutics#ClinicalStage#Investment#Healthcare#Psioxus#AkamisBio#Tumor#LifeScience#MedicalResearch#Therapy#Innovative#Impact#Technology#Platform